{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:26:09Z","timestamp":1791321969995,"version":"4.3.1"},"reference-count":45,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.3892\/ijo.2015.3193","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T04:02:30Z","timestamp":1444276950000},"page":"2057-2063","source":"Crossref","is-referenced-by-count":22,"title":["The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival"],"prefix":"10.3892","volume":"47","author":[{"given":"YOSHIFUMI","family":"TAKAHASHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YASUSHI","family":"SAGA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKAHIRO","family":"KOYANAGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUJI","family":"TAKEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SIZUO","family":"MACHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIYO","family":"TANEICHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROAKI","family":"MIZUKAMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YASUFUMI","family":"SATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIGEKI","family":"MATSUBARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROYUKI","family":"FUJIWARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"key":"key20180107191201_b1-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20180107191201_b2-ijo-47-06-2057","first-page":"91","article-title":"Surgery in advanced ovarian carcinoma: Is there proof to show the benefit?","volume":"14","author":"Heintz","year":"1988","journal-title":"Eur J Surg Oncol"},{"key":"key20180107191201_b3-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"key20180107191201_b4-ijo-47-06-2057","first-page":"951","article-title":"A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer","volume":"10","author":"Takei","year":"2003","journal-title":"Oncol Rep"},{"key":"key20180107191201_b5-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: Therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"key20180107191201_b6-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"key20180107191201_b7-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nm905","article-title":"Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth","volume":"9","author":"Fahmy","year":"2003","journal-title":"Nat Med"},{"key":"key20180107191201_b8-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"key20180107191201_b9-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: An endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"key20180107191201_b10-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: A potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"key20180107191201_b11-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1210\/endo.133.3.7689950","article-title":"The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis","volume":"133","author":"Clapp","year":"1993","journal-title":"Endocrinology"},{"key":"key20180107191201_b12-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1083\/jcb.122.2.497","article-title":"Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity","volume":"122","author":"Tolsma","year":"1993","journal-title":"J Cell Biol"},{"key":"key20180107191201_b13-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI200421152","article-title":"Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis","volume":"114","author":"Watanabe","year":"2004","journal-title":"J Clin Invest"},{"key":"key20180107191201_b14-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2004.12.073","article-title":"Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells","volume":"327","author":"Shimizu","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107191201_b15-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.2353\/ajpath.2010.090829","article-title":"Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum anti-lymphangiogenic activity and suppresses lymph node metastasis","volume":"176","author":"Heishi","year":"2010","journal-title":"Am J Pathol"},{"key":"key20180107191201_b16-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1242\/jcs.067538","article-title":"Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion","volume":"123","author":"Suzuki","year":"2010","journal-title":"J Cell Sci"},{"key":"key20180107191201_b17-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2353\/ajpath.2009.080788","article-title":"Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis","volume":"175","author":"Hosaka","year":"2009","journal-title":"Am J Pathol"},{"key":"key20180107191201_b18-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1349-7006.2008.00777.x","article-title":"Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer","volume":"99","author":"Yoshinaga","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107191201_b19-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1349-7006.2010.01812.x","article-title":"Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas","volume":"102","author":"Yoshinaga","year":"2011","journal-title":"Cancer Sci"},{"key":"key20180107191201_b20-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1349-7006.2008.01015.x","article-title":"Vasohibin-1 in human breast carcinoma: A potential negative feedback regulator of angiogenesis","volume":"100","author":"Tamaki","year":"2009","journal-title":"Cancer Sci"},{"key":"key20180107191201_b21-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1349-7006.2009.01483.x","article-title":"Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast","volume":"101","author":"Tamaki","year":"2010","journal-title":"Cancer Sci"},{"key":"key20180107191201_b22-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbrc.2006.04.176","article-title":"Vasohibin prevents arterial neointimal formation through angiogenesis inhibition","volume":"345","author":"Yamashita","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107191201_b23-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00125-008-1229-z","article-title":"Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy","volume":"52","author":"Sato","year":"2009","journal-title":"Diabetologia"},{"key":"key20180107191201_b24-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/db08-1790","article-title":"Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy","volume":"58","author":"Nasu","year":"2009","journal-title":"Diabetes"},{"key":"key20180107191201_b25-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"F873","DOI":"10.1152\/ajprenal.00503.2010","article-title":"Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis","volume":"300","author":"Saito","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"key20180107191201_b26-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajo.2008.03.019","article-title":"Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes","volume":"146","author":"Wakusawa","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key20180107191201_b27-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1167\/iovs.10-6295","article-title":"Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor","volume":"52","author":"Wakusawa","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20180107191201_b28-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jnci\/58.2.209","article-title":"Absence of HeLa cell contamination in 169 cell lines derived from human tumors","volume":"58","author":"Fogh","year":"1977","journal-title":"J Natl Cancer Inst"},{"key":"key20180107191201_b29-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9440(10)65669-6","article-title":"Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization","volume":"153","author":"Mesiano","year":"1998","journal-title":"Am J Pathol"},{"key":"key20180107191201_b30-ijo-47-06-2057","first-page":"2164","article-title":"Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model","volume":"5","author":"Wiener","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20180107191201_b31-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-1119(97)00412-5","article-title":"A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome","volume":"200","author":"Urabe","year":"1997","journal-title":"Gene"},{"key":"key20180107191201_b32-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"key":"key20180107191201_b33-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N Engl J Med"},{"key":"key20180107191201_b34-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1200\/JCO.2012.42.0505","article-title":"OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer","volume":"30","author":"Aghajanian","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107191201_b35-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"key20180107191201_b36-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"key20180107191201_b37-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"key":"key20180107191201_b38-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1096\/fj.05-5046fje","article-title":"Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization","volume":"20","author":"Shen","year":"2006","journal-title":"FASEB J"},{"key":"key20180107191201_b39-ijo-47-06-2057","first-page":"1389","article-title":"Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1","volume":"16","author":"Zhou","year":"2010","journal-title":"Mol Vis"},{"key":"key20180107191201_b40-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.22307","article-title":"Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1\/Flt-1 using adeno-associated virus serotype 1-derived vector","volume":"120","author":"Takei","year":"2007","journal-title":"Int J Cancer"},{"key":"key20180107191201_b41-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/cas.12184","article-title":"Suppression of lymph node and lung metastases of endometrial cancer by muscle-mediated expression of soluble vascular endothelial growth factor receptor-3","volume":"104","author":"Takahashi","year":"2013","journal-title":"Cancer Sci"},{"key":"key20180107191201_b42-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/gt.2008.68","article-title":"Clinical gene therapy using recombinant adeno-associated virus vectors","volume":"15","author":"Mueller","year":"2008","journal-title":"Gene Ther"},{"key":"key20180107191201_b43-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"e46459","DOI":"10.1371\/journal.pone.0046459","article-title":"Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1","volume":"7","author":"Miyashita","year":"2012","journal-title":"PLoS One"},{"key":"key20180107191201_b44-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/ph4060782","article-title":"Mutual balance between vasohibin-1 and soluble VEGFR-1 in endothelial cells","volume":"4","author":"Miyashita","year":"2011","journal-title":"Pharmaceuticals"},{"key":"key20180107191201_b45-ijo-47-06-2057","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1349-7006.2009.01388.x","article-title":"Recombinant adeno-virus encoding vasohibin prevents tumor angiogenesis and inhibits tumor growth","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3193\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:25:30Z","timestamp":1567229130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,10,8]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.3892\/ijo.2015.3193"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3193","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]}}}